Medical Licensing (MD/DO) · Independent exam preparation
ABHRS Initial Diplomate Certification: Clinical Reasoning Guide Study Guide
Practise alopecia diagnosis, durable hairline design, donor budgeting and graft safety through 60 focused concepts and original clinical drills for ABHRS preparation.
By CertMedbry · Updated 18 October 2026
Distinguish reversible shedding from progressive or scarring alopecia, plan restoration within a finite donor supply, and recognise threats to graft survival and patient safety. These 60 selective concepts connect biological mechanisms with consultation, surgical planning, medical treatment and emergency decisions. The official ABHRS outline defines the full examination scope, including anatomy, histology and embryology beyond the representative examples developed here. Use the clinical cases to explain your reasoning aloud as well as to practise written decisions.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification pathway does this guide address?
The initial American Board of Hair Restoration Surgery Diplomate pathway, which includes written and oral examinations and requires both components to be passed. Diplomate names the earned credential, not a separate examination. ABHRS provides physician specialty certification; this process does not confer medical licensure. The candidate brochure requires an existing valid M.D. or D.O. licence in good standing.
Certification and Requirements for ABHRS and IBHRS Certification · ABHRS Candidate Application Brochure
How does the Certificate of Added Qualification differ?
The brochure describes a separate written-only Certificate of Added Qualification pathway. Passing that component under that pathway does not itself confer Diplomate status. This guide uses the initial written-and-oral Diplomate pathway; it does not substitute recertification or infer that ABHRS and IBHRS administrative requirements are interchangeable.
ABHRS Candidate Application Brochure · Certification and Requirements for ABHRS and IBHRS Certification
How many questions are on the written examination?
The published Written Exam Percentages outline lists 230 written multiple-choice items. The outline and candidate brochure do not specify a scored-versus-pretest breakdown. Consult sitting-specific candidate instructions for scoring details.
ABHRS Written Exam Percentages · ABHRS Candidate Application Brochure
What item styles and oral assessment are verified?
The written outline specifies multiple-choice items. The brochure describes written assessment of knowledge and applied reasoning and oral protocols assessing simulated clinical problem solving. The 20 four-option questions here are independent learning drills. They do not reproduce the oral protocols or establish the complete range of official written item presentation.
ABHRS Written Exam Percentages · ABHRS Candidate Application Brochure
What duration, delivery method and adaptivity are established?
The published outline and candidate brochure do not specify examination duration, current delivery arrangements or adaptive testing. A multiple-choice designation alone does not establish computer adaptivity. Follow the issuer's instructions for the relevant examination sitting.
Certification and Requirements for ABHRS and IBHRS Certification · ABHRS Candidate Application Brochure · ABHRS Written Exam Percentages
Which blueprint and dates apply?
The official preparation page links the Written Exam Percentages outline. Its approximate ranges are: Scalp and hair biology 10–15%; Alopecia diagnosis and pathology 10–20%; Hair restoration surgical principles 20–30%; Donor harvesting by strip and FUE 10–20%; Graft preparation and preservation 5–10%; Recipient sites and graft placement 5–10%; Medical management of alopecia 10–20%; Perioperative pharmacology and emergencies 5–10%; Professional ethics 1–5%; History of hair restoration 1–5%. These are ranges, not one fixed distribution. The brochure filename is dated July 1, 2026. Neither document states an explicit examination effective date; the outline's October 2024 upload path is not an effective date. The percentages describe the written component, not an established oral-examination weighting.
Preparing for the Examination · ABHRS Written Exam Percentages · ABHRS Candidate Application Brochure
Where should candidates confirm passing scores, fees and preparation resources?
Confirm current passing-score information and fees with ABHRS and the instructions for the relevant sitting. The written outline does not specify them. The official preparation page lists reference resources, preparation courses and a practice examination; these are preparation resources rather than separate certification examinations. The official outline remains the full scope for study.
Certification and Requirements for ABHRS and IBHRS Certification · Preparing for the Examination · ABHRS Written Exam Percentages
This independent educational guide addresses the initial ABHRS physician Diplomate pathway. It is not ABHRS-endorsed. Its original MCQs support learning without reproducing the oral examination or predicting certification outcomes.
Outline used: Official materials linked by ABHRS and opened on 2026-10-09: Candidate Application Brochure, filename dated 07.1.2026, and the currently linked Written Exam Percentages outline. Neither document states an explicit examination effective date in the extracted text; the outline's October 2024 upload path is not an effective date. The workbook's Diplomate label denotes the credential earned through the initial certification process, including written and oral examinations, rather than a separate examination.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Scalp and hair biology10–15%
1.What distinguishes the four hair-cycle phases?
Anagen produces the growing shaft, catagen represents follicular regression, telogen is the resting interval, and exogen describes shedding. Resting and shedding therefore name different events. A shed shaft does not establish permanent loss of its follicle. When interpreting increased shedding, connect the visible event to preceding changes in cycling rather than assuming the initiating disturbance occurred that day. This distinction helps explain why a patient can lose many shafts while retaining the capacity for regrowth.
Apply it
A patient brings shed hairs collected after washing and asks whether every hair represents a destroyed follicle. Explain the difference between shaft release and follicular destruction, then assess timing, distribution and associated scalp changes.
Common pitfall: Calling telogen the active growth phase confuses the sequence. Equally, treating exogen as proof of irreversible alopecia mistakes a cycle event for structural destruction.
2.How does shortened anagen reduce visible hair coverage?
In androgenetic alopecia, susceptible follicles progressively produce finer, shorter hairs while their growth periods shorten. Coverage can decline before an area becomes visibly bare because smaller shafts contribute less bulk and do not achieve their former length. The useful biological clue is changing shaft calibre and growth behaviour, rather than simply the number of hairs noticed in the shower. Treatment assessment should therefore consider thickness and pattern as well as reported shedding.
Apply it
A man reports that his frontal hair no longer grows as long as his occipital hair. Examination shows finer frontal shafts without inflammation. Relate the length difference to shortened growth periods and follicular miniaturization.
Common pitfall: Assuming that every remaining visible hair provides its previous coverage overlooks miniaturization. A stable shaft count can coexist with a substantial reduction in cosmetic bulk.
Hair Loss and the Hair Growth Cycle · Androgenetic Alopecia: A Guide to Pattern Hair Loss
3.What makes a follicular unit an anatomical structure?
A follicular unit is a naturally occurring grouping of follicles with associated sebaceous structures, arrector pili attachments and supporting tissue. It is not synonymous with one hair. This anatomy explains why transplantation inventories must distinguish units from individual follicles and why tissue preservation matters during harvesting. A surface follicular group can contain closely adjacent units, so visible clustering does not establish a single anatomical unit. Magnification helps identify the actual grouping, particularly where follicles travel obliquely beneath the surface. A natural anatomical unit and a surgically prepared graft describe related but different things.
Apply it
During graft review, a trainee labels a three-hair natural grouping as three follicular units. Correct the record to one unit containing three hairs, and preserve separate graft and hair totals for subsequent planning.
Common pitfall: Using follicular unit, follicle and graft interchangeably inflates or obscures inventories. A graft can contain one unit, part of a grouping or multiple units.
Follicular Unit Transplantation & Extraction · Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
4.Which scalp layers explain mobility and surgical bleeding?
From superficial to deep, the scalp comprises skin; subcutaneous fat and fibrous tissue; galea; loose connective tissue; and pericranium. Most scalp vessels, lymphatics and nerves occupy the subcutaneous layer. The galea is a strong aponeurotic layer, whereas the loose connective tissue beneath it permits scalp movement over deeper structures. The pericranium covers the skull. These relationships distinguish the mobile plane from the vessel-bearing tissue and explain why scalp incisions can bleed substantially. See the [ISHRS scalp-anatomy description](https://ishrs.org/why-your-hair-restoration-specialist-should-be-physician/).
Apply it
When reviewing a surgical cross-section, identify the subcutaneous neurovascular layer above the galea and the loose mobile plane below it. Explain why scalp mobility does not imply that superficial surgical tissue has little blood supply.
Common pitfall: The galea and loose connective tissue are separate layers. Confusing their positions also obscures the relationship between the main superficial neurovascular tissue and the mobile deeper plane.
5.How does donor dominance support transplantation?
Donor dominance describes the retention of important donor hair characteristics after transplantation to a recipient area. Relatively androgen-resistant scalp follicles can continue growing after transfer into a region affected by pattern loss. The principle supports transplantation but does not make every donor location equally durable or guarantee survival after injury. Its practical implication is to select genuinely suitable donor hair and preserve its viability, rather than expecting the recipient site to transform unstable follicles into permanent ones.
Apply it
A patient asks why moving occipital follicles to a thinning frontal region can work. Explain retained donor characteristics, then examine whether the proposed donor region itself shows miniaturization before describing expected durability.
Common pitfall: Donor dominance is not a guarantee for hair harvested from any location. Susceptible donor follicles and poorly handled grafts remain limitations despite transplantation.
Androgenetic Alopecia: A Guide to Pattern Hair Loss · ISHRS Hair Restoration Glossary
6.Which microscopic structures distinguish a follicle from its hair shaft?
The shaft is keratin produced by the follicle. Surrounding follicular structures include the inner root sheath, outer root sheath and connective tissue sheath; the dermal papilla is another distinct component assessed when examining harvested tissue. A stem-cell reservoir associated with the bulge supports regenerative capacity during cycling. These structures make the follicle a living organ rather than simply a buried shaft. The [ISHRS microscopic description](https://ishrs.org/follicular-unit-extraction-fue-manual-and-powered-device-assisted/) connects cellular layers and regenerative structures to the importance of avoiding harvesting injury.
Apply it
A specimen contains a conspicuous shaft but little supporting tissue. Under magnification, assess its sheaths and lower follicular structures before classifying it as an intact graft; a plucked specimen may leave essential structures behind.
Common pitfall: Shaft length does not demonstrate preserved follicular anatomy. Likewise, identifying one retained sheath does not establish that all components accompanied the specimen.
Hair Loss and the Hair Growth Cycle · Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
7.How does embryonic follicle formation differ from adult hair cycling?
During follicle development, molecular communication between epidermal epithelium and underlying mesenchymal cells induces an epithelial bud. Further signalling guides elongation and differentiation; melanocytes and sebaceous structures become incorporated as the follicle develops. This establishes the organ that later undergoes repeated growth cycles. Normal adult cycling renews hair production within existing follicles rather than routinely creating additional follicles. The [ISHRS account of follicle origin](https://ishrs.org/hair-follicle-origin/) describes this developmental sequence and the distinction between fetal follicle formation and adult follicular activity.
Apply it
A patient assumes that a treatment increasing the number of visible hairs must have generated new follicles. Explain how existing follicles can resume or improve shaft production without repeating embryonic follicle formation.
Common pitfall: Regrowth is not proof of new follicle formation. Increased visible coverage can reflect altered cycling or shaft calibre within an existing follicular population.
ABHRS Written Exam Percentages · Hair Loss and the Hair Growth Cycle
Alopecia diagnosis and pathology10–20%
8.Which findings favour androgenetic alopecia?
Gradual patterned thinning with progressive variation in shaft calibre supports androgenetic alopecia. Men commonly show frontal recession or vertex involvement, while women often develop central thinning. The process reflects miniaturization of susceptible follicles rather than an isolated episode of synchronized shedding. Pain, redness or other inflammatory findings should prompt investigation for an additional or alternative disorder. A family history can support the assessment, but its absence does not exclude a variably expressed inherited condition.
Apply it
A patient describes several years of painless crown thinning. Examination finds mixed fine and thick shafts in the affected region and better preserved occipital hair. Use the combined chronology, distribution and calibre changes to support the diagnosis.
Common pitfall: A family member with dense hair does not rule out androgenetic alopecia. Conversely, family history alone cannot explain inflammatory signs in the patient's scalp.
9.How should Norwood and Ludwig classifications be applied?
Norwood describes male pattern distribution and severity. Representative distinctions are limited frontotemporal recession in stage II; deeper frontotemporal recession in stage III; a vertex focus in stage III vertex; and distinct frontal and vertex loss separated by a remaining band in stage IV. That separating band becomes narrower and sparser in stage V. In stage VI, frontal and vertex loss become confluent after the bridge is lost; stage VII leaves a narrow peripheral horseshoe of hair. Ludwig describes progressively increasing central thinning, usually with relative preservation of the frontal margin: grade I is mild central thinning, grade II shows more pronounced thinning and scalp visibility, and grade III shows severe central depletion. Use the ISHRS classification illustrations to compare morphology. These scales describe appearance; they do not independently establish diagnosis or determine graft demand.
Apply it
Classify three representative patterns: deep frontotemporal recession without a vertex focus fits Norwood III; distinct frontal and vertex loss with a preserved separating band fits Norwood IV; confluent frontal–vertex loss without that bridge fits Norwood VI. Then arrange mild, moderate and severe central thinning with a relatively retained frontal margin as Ludwig I, II and III. Separately assess donor stability, recipient area and hair characteristics before estimating grafts.
Common pitfall: A classification is descriptive shorthand, not proof of androgenetic disease, a prediction of inevitable progression through every stage or a graft prescription. Similar stages can coexist with very different donor capacity and treatment needs.
10.When does delayed shedding suggest telogen effluvium?
Telogen effluvium often becomes noticeable a few months after a physiological or psychological stressor, such as illness, childbirth, surgery or substantial weight loss. The delay is compatible with altered cycling before shafts are shed. Diffuse shedding after an appropriate trigger differs from years of progressive patterned miniaturization. Recovery is possible when the disturbance resolves, although ongoing stressors can prolong shedding. Establish the chronology before interpreting a dramatic current hair count as permanent donor or recipient loss.
Apply it
A patient develops diffuse shedding several months after a febrile illness. The scalp lacks a new focal inflammatory pattern. Build a timeline connecting the illness to later shedding and assess for concurrent patterned thinning.
Common pitfall: Searching only for an event in the preceding few days can miss the relevant trigger. A plausible stressor also does not exclude coexisting androgenetic alopecia.
11.Which clues raise concern for frontal fibrosing alopecia?
Progressive frontal hairline change accompanied by eyebrow loss, itching or pain warrants assessment for frontal fibrosing alopecia rather than automatic attribution to ordinary pattern recession. FFA can cause permanent loss, making recognition and stabilization important. Examination should include the hairline, scalp and eyebrows, and suspected disease may require biopsy. The diagnostic decision depends on the combination of distribution, symptoms and tissue findings; a photograph of recession alone cannot establish whether the process is inflammatory.
Apply it
A woman seeking hairline restoration reports eyebrow thinning and persistent itching along the receding border. Examine these regions together and investigate suspected inflammatory disease before committing donor grafts to a cosmetic reconstruction.
Common pitfall: Treating every receding frontal hairline as androgenetic loss can miss a destructive process. Cosmetic camouflage does not establish control of the underlying disease.
12.When does scalp biopsy add diagnostic value?
Biopsy can clarify suspected scarring alopecia or an uncertain mixture of disorders by allowing microscopic examination of scalp tissue. It adds information about the disease process that surface pattern alone may not resolve. In suspected FFA, integrate tissue findings with symptoms, examination and progression rather than treating pathology as an isolated label. FFA can coexist with patterned thinning or traction alopecia, so one diagnosis need not explain every region. Separate observations by location and chronology, and use tissue examination to answer diagnostic uncertainty that changes treatment.
Apply it
A patient has frontal recession with discomfort and central thinning of a different appearance. Explain that a biopsy may help identify more than one process and guide treatment directed at each rather than one uniform intervention.
Common pitfall: Biopsy is not automatically required for every classic patterned presentation. Its value is greatest when the findings answer a meaningful diagnostic uncertainty affecting care.
Frontal Fibrosing Alopecia: Diagnosis and Treatment · Androgenetic Alopecia: A Guide to Pattern Hair Loss
13.Why must donor miniaturization affect the diagnosis and plan?
The donor region must be examined rather than assumed to be permanent simply because it lies posteriorly or laterally. Miniaturization or diffuse thinning there changes the estimate of durable donor supply and may undermine an otherwise attractive recipient plan. The key distinction is between hair that is present today and hair likely to provide lasting coverage after transfer. Document donor quality separately from recipient severity, especially in diffuse presentations and previously harvested scalps.
Apply it
A patient has extensive central thinning and fine, sparse hair throughout the proposed donor field. Reconsider transplantation capacity before calculating recipient coverage; a large apparent donor surface does not compensate for unstable or poor-quality follicles.
Common pitfall: Anatomical location alone does not establish donor suitability. Counting all visible posterior hairs as permanent can substantially overstate the available long-term reconstructive reserve.
Androgenetic Alopecia: A Guide to Pattern Hair Loss · Guide to FUE Hair Transplant: Benefits, Process & Recovery
14.How does anagen effluvium differ mechanistically from telogen effluvium?
Anagen effluvium disrupts actively growing hair, commonly after cytotoxic chemotherapy, and can begin within about two to four weeks of treatment. Telogen effluvium follows a shift in cycling and typically becomes apparent months after a trigger. Contrast both with gradual patterned miniaturization and with symptomatic inflammatory loss. Establish medication exposure, illness, weight change and the interval to onset rather than diagnosing from shedding volume alone. See the [ISHRS description of anagen effluvium](https://ishrs.org/patients/types-of-hair-loss/).
Apply it
Compare rapid hair loss three weeks after chemotherapy with diffuse shedding three months after illness. The first chronology supports injury during active growth; the second supports a delayed telogen response. Coordinate medication decisions with the treating prescriber.
Common pitfall: Not every drug-associated loss is anagen effluvium, and not every diffuse loss is telogen effluvium. Some chemotherapy-associated loss can persist, so rapid onset does not guarantee complete recovery.
Do You Have Hair Loss or Hair Shedding? · Hair Loss and the Hair Growth Cycle · Androgenetic Alopecia: A Guide to Pattern Hair Loss
Hair restoration surgical principles20–30%
15.When is diagnostic clarification more valuable than immediate surgery?
Surgical candidacy begins with the cause and behaviour of hair loss, not the requested graft number. Potentially reversible shedding and active inflammatory disease require different decisions from established stable pattern loss. Transplantation redistributes a finite resource and cannot correct every ongoing cause of loss. Resolve findings that materially change prognosis before selecting the technique. The useful decision is whether surgery addresses the patient's actual disease and goals with an acceptable long-term donor commitment.
Apply it
A patient requests urgent transplantation during a new diffuse shedding episode after illness. Assess the episode and expected recovery before designing a permanent redistribution of donor hair to an appearance that may change substantially.
Common pitfall: A willingness to pay or a technically harvestable donor field does not establish an indication. Diagnosis and expected disease course must support the procedure.
Hair Graft Placement: The Final Step in Hair Transplantation · Do You Have Hair Loss or Hair Shedding?
16.Why does early progressive loss require conservative planning?
In a young patient, the recipient area may enlarge for many years while donor supply remains finite and is depleted by each procedure. Rapid recent loss increases concern that today's small defect understates future demand. A durable plan considers possible progression, medical management and future reconstruction before committing to a low or broad hairline. The objective is a result that remains coherent if surrounding native hair thins, rather than a design dependent on its permanent preservation.
Apply it
A young man with rapidly advancing recession requests dense temple closure. Discuss likely future demand, assess donor reserve and consider a more conservative design that remains supportable if frontal and mid-scalp loss expands.
Common pitfall: Designing solely around the current bald area ignores future recipient expansion. Family history informs risk but cannot precisely predict an individual's final pattern.
About Your New Hairline · Harvesting of Donor Hair for Hair Transplants
17.How does hairline position change lifetime graft demand?
Lowering or widening a planned hairline increases the surface requiring coverage and commits grafts to a permanent visible boundary. Future loss behind that boundary may require further reconstruction to maintain continuity. Hairline design therefore combines facial framing, patient preferences, donor capacity and anticipated progression. A technically possible low hairline is not automatically a sustainable choice. Compare complete long-term designs rather than evaluating only how attractive the first postoperative frontal photograph might look.
Apply it
Two proposed hairlines look acceptable, but one creates a substantially larger recipient area. Compare their graft requirements and reserve implications with the patient before agreeing on a design that can withstand continued native hair loss.
Common pitfall: A youthful reference photograph can be persuasive but does not establish a sustainable surgical boundary. Hairline placement must remain compatible with future donor limitations.
18.How should a finite donor budget constrain coverage?
Recipient wishes must be reconciled with the number and characteristics of grafts that can be harvested while preserving acceptable donor appearance and future options. When demand exceeds supply, change coverage priorities, treated area or planned density rather than assuming additional harvesting is harmless. The donor budget is patient-specific and affected by prior procedures and future loss. A transparent plan shows what the available grafts can accomplish and what would remain untreated or deferred.
Apply it
An exercise plan requires 3,000 grafts, but only 2,200 are allocated after donor assessment. Revise the recipient design or stage selected areas instead of quietly expanding the harvest to meet the original estimate.
Common pitfall: Recipient demand does not determine safe donor capacity. A larger session can satisfy an immediate numerical target while creating a lasting donor appearance problem.
Harvesting of Donor Hair for Hair Transplants · Guide to FUE Hair Transplant: Benefits, Process & Recovery
19.How is recipient graft demand calculated?
For a stated exercise, required grafts equal recipient area multiplied by planned additional graft density, using compatible units. Keep grafts per square centimetre separate from hairs per square centimetre. The result is a planning estimate, not proof that the proposed density is clinically appropriate or that every graft will grow. Real decisions also consider native hair, shaft characteristics, donor limitations and tissue conditions. State the assumptions before interpreting the arithmetic as a treatment plan.
Apply it
For an exercise area of 42 cm² and an assumed additional density of 30 grafts/cm², calculate 1,260 grafts. Record that these are illustrative planning inputs rather than a universal recommended implantation density.
Common pitfall: Multiplying area by hair density and reporting grafts changes the unit. Also distinguish additional transplanted density from a target that includes existing native hair.
20.How should demand be calculated across different recipient zones?
When zones have different planned additional densities, calculate each area's demand separately and add the results. An unweighted average of densities can be misleading when zone sizes differ. This arithmetic makes trade-offs visible: reducing one large zone may release more grafts than adjusting a small zone by the same density amount. The numerical exercise supports an explicit allocation discussion; it does not establish that a particular distribution is aesthetically or medically appropriate.
Apply it
Assume 25 cm² at 32 grafts/cm² and 35 cm² at 20 grafts/cm². The separate requirements are 800 and 700 grafts, giving 1,500 total. Compare that total with the stated donor allocation.
Common pitfall: Averaging two density values without weighting by area can misstate demand. Always preserve the area-density pairing before summing graft requirements across zones.
21.Why must existing native hair be assessed separately?
A thinning recipient region contains a mixture of native hair and spaces considered for grafts. Native hair contributes to current appearance but may continue to miniaturize after transplantation. Separate its present contribution from the intended transplanted contribution and from its uncertain future durability. This avoids promising a lasting density based on hair that is already declining. Medical management and follow-up can be important because successful graft growth does not prevent progression in neighbouring susceptible follicles.
Apply it
A patient with substantial miniaturized frontal hair requests a small graft addition and permanent fullness. Explain which part of today's coverage comes from vulnerable native hair and how further loss could change the result.
Common pitfall: Counting miniaturized native hairs as permanently preserved coverage can understate future demand. A successful transplant does not freeze the surrounding androgenetic process.
22.Why do equal graft counts produce different cosmetic coverage?
Coverage depends on more than the number of grafts. Shaft calibre, curl or wave, hair colour, skin contrast and hairs per graft influence how much scalp remains visible. Consequently, two patients receiving equal graft counts can have different appearances without a difference in technical survival. Assess these characteristics when setting expectations and assigning grafts. Numerical density is useful, but it does not replace an individualized estimate of visual coverage and the patient's preferred hairstyle.
Apply it
Two patients request identical coverage from the same graft count. One has coarse wavy hair and the other fine straight hair. Explain why their likely visual results differ and adjust expectations before choosing recipient priorities.
Common pitfall: A graft-count comparison between patients can imply equivalence that their hair characteristics do not support. Counts describe inventory, while appearance reflects several interacting variables.
Harvesting of Donor Hair for Hair Transplants · Guide to FUE Hair Transplant: Benefits, Process & Recovery
23.Which graft characteristics suit the frontal transition?
The frontal transition requires a visually soft boundary, so fine single-hair grafts serve a different purpose from larger multi-hair grafts placed farther behind it. Graft selection is therefore an allocation decision, not simply a count of available tissue pieces. Match the number and calibre of hairs to the intended region while preserving enough appropriate singles for the visible edge. A dense frontal boundary can still look unnatural if the selected grafts create conspicuous coarse clusters.
Apply it
The inventory contains fine singles and coarse three-hair grafts. Reserve suitable singles for the leading transition and use larger grafts in regions where added bulk is desired, rather than exhausting the singles elsewhere.
Common pitfall: More hairs per graft is not always better. At a visible hairline edge, excessive cluster size or calibre can undermine naturalness despite good growth.
Harvesting of Donor Hair for Hair Transplants · Hair Graft Placement: The Final Step in Hair Transplantation
24.How should crown reconstruction fit the overall plan?
The crown is a distinct region with a swirl or spiral growth pattern, and its coverage must be considered alongside frontal and mid-scalp needs. A broad crown can consume a substantial share of a finite donor allocation. Discuss the patient's priorities and the consequences for other regions before committing grafts. The decision concerns both geometry and resource distribution: crown sites must follow local direction, while the overall plan must remain supportable if surrounding loss progresses.
Apply it
A patient prioritizes crown coverage but also has an untreated frontal defect and limited donor reserve. Compare region-specific plans and explain what allocating most grafts to the crown would leave available for frontal framing.
Common pitfall: Treating the crown as an isolated defect can exhaust resources needed elsewhere. Its natural swirl also cannot be reproduced by uniformly forward-directed placement.
ISHRS Hair Restoration Glossary · Harvesting of Donor Hair for Hair Transplants
25.When does staged restoration improve planning?
Staging can divide extensive restoration into deliberate phases, allowing donor allocation and recipient priorities to be reconsidered as growth and disease behaviour become clearer. It is especially relevant when complete coverage cannot be responsibly achieved in one commitment. Each stage should have a coherent objective and a defined effect on remaining reserves. Staging does not create additional donor hair; its value lies in sequencing decisions and preserving flexibility rather than postponing an unavoidable supply-demand mismatch.
Apply it
A patient seeks extensive frontal and crown reconstruction with a restricted donor allocation. Design an initial stage with an acceptable standalone appearance, then explain which later decisions depend on growth, progression and remaining reserve.
Common pitfall: Calling an excessive plan staged does not make its total donor demand sustainable. Calculate the cumulative commitment rather than assessing each session in isolation.
Harvesting of Donor Hair for Hair Transplants · Hair Graft Placement: The Final Step in Hair Transplantation
26.How can photographs distinguish treatment change from presentation change?
Photographic comparison is most informative when lighting, angle, hair arrangement and visible scalp regions are reasonably consistent. Otherwise, apparent improvement can reflect presentation rather than biological change. Images should document donor appearance as well as recipient results and be interpreted alongside treatment history and examination. In clinical follow-up, the purpose is to evaluate change accurately; in professional communication, the same principle helps prevent misleading claims about density, growth or the effect of a particular procedure.
Apply it
A follow-up image appears fuller, but it uses longer hair and softer lighting than baseline. Obtain a more comparable series before concluding that the difference measures growth attributable to the surgical procedure alone.
Common pitfall: An attractive photograph is not automatically an informative comparison. Differences in styling and illumination can obscure residual thinning or exaggerate the apparent treatment effect.
ABHRS Candidate Application Brochure · ABHRS/IBHRS Code of Ethics Policy Statement
27.What expectations should be resolved before surgical consent?
Consent should connect the patient's desired appearance with what redistribution of their own hair can reasonably achieve. Discuss donor limitations, scar patterns, possible staged treatment and continued loss of native susceptible hair. Agreement on a graft count alone does not establish agreement on the outcome. The discriminating issue is whether the patient understands the likely appearance and long-term commitments, including limitations that remain even when the procedure is technically successful and the transplanted follicles grow.
Apply it
A patient accepts the planned graft count but expects original youthful density, no visible scars with shaving and no future treatment. Resolve these specific expectations before proceeding because they conflict with material limits of transplantation.
Common pitfall: A signed form cannot substitute for correcting a concrete misunderstanding. Technical success may still disappoint when the patient expects unlimited density or scarless harvesting.
Hair Graft Placement: The Final Step in Hair Transplantation · Guide to FUE Hair Transplant: Benefits, Process & Recovery · About Your New Hairline
Donor harvesting by strip and FUE10–20%
28.How should a strip harvest be planned and closed?
Strip harvesting removes hair-bearing donor tissue that is subsequently dissected into grafts and leaves a linear donor scar. Plan strip width in relation to scalp laxity, prior surgery and the ability to approximate the wound with minimal tension. Increasing width to chase a graft target can increase closure tension and the risk of scar widening; an excessively wide harvest or tight closure can also threaten healing. Careful dissection along the incision line limits injury to adjacent follicles. Loss of these follicles can make the scar appear broader even without true scar stretching. Microscopic strip processing addresses a separate opportunity for follicular injury. Trichophytic closure can improve camouflage by allowing hair to grow through the scar, but it does not remove the need for appropriate width and minimal-tension closure.
Apply it
A patient has restricted donor laxity after previous strip surgery. The proposed wider strip would provide more tissue but require tight approximation. Reduce the planned width and revise the expected graft yield and recipient allocation. During incision-line dissection, preserve adjacent follicles; during processing, use direct visualization to limit further injury. Explain that a camouflage technique cannot compensate for an unsuitable high-tension plan.
Common pitfall: Strip size does not equal usable graft yield, and a wider strip is not automatically a better harvest. Distinguish true scar widening from apparent widening caused by incision-line follicular loss; both require prevention.
Harvesting of Donor Hair for Hair Transplants · Follicular Unit Transplantation & Extraction · COMPARISON BETWEEN STRIP HARVESTING AND FOLLICULAR UNIT EXTRACTION: A FAIR AND BALANCED VIEW - ISHRS
29.What does follicular unit excision actually involve?
Follicular unit excision involves cutting around a targeted follicular grouping and removing the resulting tissue graft. The accepted expansion of FUE emphasizes that this is a surgical excision, not simply pulling out hairs. Incision and extraction are linked steps, and success depends on releasing the graft while preserving its structures. Older references commonly use follicular unit extraction; recognizing that historical wording helps interpret literature without misrepresenting the procedure as nonsurgical or inherently free of scars.
Apply it
A patient believes FUE uses suction to remove hairs without incisions. Explain the circumferential cutting and tissue-removal steps, then discuss the small donor wounds and the importance of appropriate surgical training and planning.
Common pitfall: The older word extraction can suggest a nonsurgical process. Neither the terminology nor the small wound size removes the procedure's surgical risks.
Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
30.How do strip and FUE donor scars differ?
Strip harvesting creates a linear donor scar, whereas FUE creates multiple small excision scars that may appear as pale dots. FUE avoids a linear scar but is not scarless. Visibility depends partly on healing, skin and hair characteristics, harvest pattern and hairstyle. Explain the type of scar rather than promising invisibility. A patient who plans a closely cropped style needs a realistic discussion of both residual density and the potential visibility of excision sites.
Apply it
A patient chooses FUE because they intend to shave the donor region completely. Show how small dispersed scars and reduced density may still become visible, and compare that trade-off with the linear scar from strip harvesting.
Common pitfall: No linear scar does not mean no scar. Hair length that conceals one pattern of scarring may not conceal every donor change.
Guide to FUE Hair Transplant: Benefits, Process & Recovery · Follicular Unit Transplantation & Extraction
31.Why does harvest distribution matter as much as total graft count?
A donor field can look depleted when excisions are concentrated, even if the overall session count appears modest. Assess local density, prior scars and the spacing of proposed removals rather than relying only on a whole-scalp total. Repeated harvesting can compound irregularity where previous excisions have already reduced coverage. The relevant endpoint is an acceptable remaining donor appearance and reserve, not merely achieving the planned recipient inventory through the fastest accessible patch of scalp.
Apply it
During repeat FUE planning, one donor patch is already visibly thinner than adjacent regions. Map prior depletion and revise the harvest distribution instead of applying the same removal density uniformly across the entire proposed field.
Common pitfall: An acceptable average donor density can conceal severely depleted local areas. Whole-field arithmetic does not justify repeated concentrated harvesting from an already thin patch.
FUE Clinical Practice Guidelines — July 15, 2019 · Guide to FUE Hair Transplant: Benefits, Process & Recovery
32.Why should harvesting stay within an assessed durable donor region?
Expanding the harvest into less durable regions may provide more grafts immediately but introduces follicles at risk of future miniaturization and can expose scars as surrounding hair thins. The safe donor concept is therefore a long-term assessment, not permission to use every currently hair-bearing area. Examine pattern, donor quality and prior surgery when defining the available field. If suitable supply is insufficient, revise recipient goals rather than treating geographical expansion as a harmless solution.
Apply it
A planned session runs short of grafts and the patient suggests harvesting beyond the assessed donor boundary. Reconsider the recipient allocation because present hair growth outside that boundary does not establish lasting suitability.
Common pitfall: A larger donor surface is not necessarily a larger permanent reserve. Extending the field can transfer unstable hair and create future visible donor defects.
Guide to FUE Hair Transplant: Benefits, Process & Recovery · Androgenetic Alopecia: A Guide to Pattern Hair Loss
33.How does subsurface follicular splay affect FUE?
Follicles within a group can diverge beneath the surface, particularly in their lower portions. A punch following only the visible emergence angle may therefore intersect a follicle whose deeper course differs. Splay can be anatomical, and the terminology guidance also describes splay associated with harvesting forces and loss of supporting tissue. Assess extracted grafts under magnification and adapt technique to observed anatomy rather than assuming the surface cluster behaves as a parallel cylinder.
Apply it
Early specimens from a donor region show injury concentrated in divergent lower follicles. Reassess alignment, depth and instrument choice using microscopic feedback before continuing the same settings across the rest of the field.
Common pitfall: Perfect alignment with the visible shaft does not guarantee alignment with every deeper follicle. Surface appearance alone cannot exclude significant subsurface divergence.
Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
34.What distinguishes capping from force-related follicular fracture?
Capping yields a superficial tissue cap without the intended terminal follicles, often because adequate release was not achieved. Fracture describes a follicle broken into pieces and can result from excessive extraction force. Both reduce harvest quality, but they suggest different aspects of the process requiring review. Microscopic inspection identifies the actual injury pattern. Repeatedly pulling harder at a resistant graft can worsen damage rather than compensate for incomplete release or unsuitable instrument positioning.
Apply it
Several specimens contain only superficial caps, and extraction requires increasing force. Stop to reassess release depth and technique, then inspect for additional fractured or stripped follicles rather than counting every removed tissue fragment as usable.
Common pitfall: A superficial cap is not an intact graft merely because skin was removed. Escalating traction without identifying the problem can add further injury.
Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
35.How do graft and follicle transection rates differ?
Graft transection rate counts grafts containing at least one transected follicle divided by all excised grafts. Follicle transection rate counts transected follicles divided by all excised follicles, including intact and transected follicles. These answer different questions because a multi-follicle graft can retain intact follicles despite one injury. Specify the denominator whenever reporting a percentage. A graft-level rate cannot be interpreted as the percentage of all follicles injured without additional inventory information.
Apply it
An exercise sample contains 100 grafts and 240 follicles. Twenty grafts each contain one transected follicle. Report a 20% graft transection rate and approximately 8.3% follicle transection rate, with both denominators stated.
Common pitfall: Reporting only a transection percentage hides the counting unit. Partially injured multi-hair grafts make graft-level and follicle-level rates numerically different.
Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
Graft preparation and preservation5–10%
36.How should graft and hair inventories be reconciled?
Track grafts by configuration and calculate hairs separately. Total grafts equal the number of tissue pieces; total hairs require multiplying each category by its hair count before summing. Reconcile the prepared, available and placed inventories so tissue loss or unusable specimens are not silently included in the clinical record. An accurate inventory supports recipient allocation and quality review, but the number of visible hairs in prepared grafts does not by itself establish eventual survival or growth.
Apply it
An exercise tray holds 120 singles, 180 doubles and 100 triples. It contains 400 grafts and 780 hairs. Record both totals before reserving appropriate singles for the planned frontal transition.
Common pitfall: Multiplying every graft by an assumed average can conceal a changed configuration mix. Use the actual categorized inventory when those counts are available.
Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
37.Why should grafts be inspected and sorted under magnification?
Magnified evaluation identifies hair number, preserved anatomy and injuries such as transection or fracture that may be missed during rapid handling. Sorting then supplies appropriate configurations for different recipient regions. Quality findings should be communicated promptly so the surgeon can adjust harvesting or placement before a small problem becomes widespread. Inspection is therefore an active feedback step, not simply a final count. Record whether conclusions come from every graft or from a defined sample.
Apply it
A quality sample reveals more partially transected grafts than earlier samples. Notify the surgeon immediately, review the affected donor region and technique, and keep the sample method clear when interpreting the observed rate.
Common pitfall: Finishing the entire harvest before reviewing quality loses the opportunity to prevent repeated injury. A small sample also should not be presented as a complete count.
38.Why is continuous graft hydration essential?
Excised grafts are vulnerable to desiccation, which can injure living follicular tissue before implantation. FUE grafts may carry relatively little protective perifollicular tissue, making disciplined handling especially important. Maintain hydration throughout sorting, transfer and placement rather than considering storage alone. A short unprotected interval on an exposed surface is a different problem from a long interval in an appropriate holding medium. Workflow should prevent drying rather than depend on noticing visible damage afterward.
Apply it
A placement delay leaves sorted grafts exposed on a work surface. Restore protected hydrated handling immediately and change the transfer workflow so waiting grafts remain in their holding medium until they are needed.
Common pitfall: A graft that still looks moist may already have experienced damaging exposure. Rewetting should not be assumed to reverse all prior desiccation injury.
39.How do storage conditions and time outside the body interact?
After excision, grafts lose their normal blood supply and encounter physiological stress before and after implantation. The FUE guidance identifies out-of-body time, holding medium and ischemia-reperfusion injury as relevant factors. Appropriate preservation supports viability but does not justify avoidable delay or careless handling. Coordinate harvest, preparation and placement so grafts spend less unnecessary time waiting. Do not turn a particular holding solution into an unsupported guarantee of survival regardless of the rest of the procedure.
Apply it
The harvest team is producing grafts faster than the placement team can use them. Adjust the sequence or staffing and protect the waiting inventory rather than assuming the holding medium makes a growing backlog irrelevant.
Common pitfall: No universal safe waiting period follows from naming a storage solution. Preservation quality and efficient workflow must be considered together for the actual grafts.
40.How does repeated placement trauma threaten graft quality?
Repeated unsuccessful insertion attempts expose a graft to additional manipulation and mechanical injury. The FUE guidance identifies repetitive placement trauma as a threat to survival and cosmetic outcome. Resistance should prompt assessment of site suitability, graft configuration and technique rather than escalating force. Efficient placement means minimizing unnecessary handling while retaining control, not simply increasing speed. A well-preserved graft can still be damaged at the final stage if mismatches or technical difficulties are ignored.
Apply it
A graft repeatedly buckles during insertion into one recipient site. Pause to inspect graft condition and site compatibility, then correct the cause rather than repeatedly forcing the same graft through an unsuitable opening.
Common pitfall: Repeated attempts are not harmless because the graft was initially intact. More force can convert a site-fit problem into irreversible tissue damage.
Recipient sites and graft placement5–10%
41.How do recipient angle and direction shape the result?
Recipient sites establish the angle at which hair emerges and the direction it follows across the scalp. These are related but distinct properties: a site can have an appropriate shallow angle yet point in the wrong direction. Match local growth patterns and the intended hairline or crown geometry rather than using a uniform orientation everywhere. Correct graft survival cannot compensate for an unnatural growth pattern, so directional design must be resolved before the graft is seated.
Apply it
A proposed crown layout uses shallow sites that all point forward. Preserve appropriate emergence angles but redesign the directional pattern to follow the patient's crown swirl instead of treating shallow angle alone as sufficient.
Common pitfall: Angle and direction are not interchangeable. A technically shallow site can still produce conspicuous misdirection if its orientation conflicts with neighbouring hair.
Hair Graft Placement: The Final Step in Hair Transplantation · ISHRS Hair Restoration Glossary
42.Why must recipient-site size match the graft?
A recipient opening must accommodate the actual tissue graft rather than an assumed standardized specimen. An undersized opening can make insertion difficult and encourage repeated trauma, while an oversized opening provides a poor fit. Evaluate tissue bulk and configuration alongside the planned site-making instrument. The practical aim is controlled placement with minimal manipulation. If a graft repeatedly resists insertion, reconsider the match instead of treating every difficulty as a reason to increase force or speed.
Apply it
Several bulky grafts meet resistance in sites prepared for smaller specimens. Reassess graft selection and site dimensions before proceeding; avoid repeatedly compressing or pushing the grafts merely to maintain the planned pace.
Common pitfall: One site dimension need not fit every graft category. Matching only the number of hairs overlooks differences in accompanying tissue bulk and configuration.
Hair Graft Placement: The Final Step in Hair Transplantation · FUE Clinical Practice Guidelines — July 15, 2019
43.How should recipient depth be matched to graft anatomy?
Recipient depth must receive the follicular tissue appropriately and support its contact with a viable tissue bed. A shallow or otherwise mismatched site can prevent proper seating, while excessively deep placement can distort the intended surface relationship. Assess graft length and anatomy rather than using one depth for all specimens. The ISHRS placement reference emphasizes correct depth and adequate blood supply; these are functional requirements, not simply aesthetic adjustments to the visible hair shaft.
Apply it
A graft remains poorly seated despite an opening wide enough to accept it. Assess whether site depth matches the specimen before changing width or applying more pressure, and confirm the intended surface position after correction.
Common pitfall: An adequately wide opening can still have unsuitable depth. Increasing width alone will not correct every seating problem and may worsen site fit.
Hair Graft Placement: The Final Step in Hair Transplantation
44.What distinguishes sharp and blunt implanter workflows?
The 2019 terminology guidance distinguishes sharp implanters, which can create a recipient site while placing the graft, from blunt implanters used with premade sites. The distinction concerns the device's role in site creation, not proof that one workflow guarantees better growth. Both still require appropriate graft handling, anatomical placement and direction. Describe the actual sequence when discussing a technique, because the general word implanter does not establish whether recipient incisions were created beforehand.
Apply it
An operative description states that grafts were delivered through a blunt implanter. Confirm that recipient sites were prepared separately and document that workflow, rather than assuming the device simultaneously cut each opening during delivery.
Common pitfall: An implanter label does not identify the complete technique. Device marketing should not replace an anatomical description of site creation and graft placement.
Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
Medical management of alopecia10–20%
45.How should finasteride's mechanism, dose and adverse effects be explained?
Finasteride inhibits type II 5-alpha-reductase, reducing conversion of testosterone to dihydrotestosterone. The U.S. labeled dose for male pattern hair loss is 1 mg orally once daily; efficacy in bitemporal recession has not been established. Counsel about decreased libido, erectile dysfunction and ejaculation disorders. In the first-year trials, at least one of these sexual adverse experiences occurred in 3.8% with finasteride versus 2.1% with placebo; resolution occurred in those who stopped because of these effects and in most who continued. Postmarketing reports include sexual dysfunction continuing after discontinuation. Voluntary reports cannot reliably establish its frequency or a causal relationship.
Apply it
Before starting treatment, explain the 1-mg daily regimen, the androgen-conversion mechanism and sexual adverse effects. Distinguish trial rates and outcomes from postmarketing reports, and arrange review of bothersome or persistent symptoms.
Common pitfall: Trial findings do not justify promising that every sexual symptom will resolve promptly. Postmarketing reports also do not supply a reliable incidence of persistent dysfunction. Finasteride does not create new follicles or guarantee temple restoration.
46.Why do broken finasteride tablets require pregnancy precautions?
Dihydrotestosterone contributes to normal development of male external genitalia, so exposure to finasteride during pregnancy presents a fetal risk. The prescribing information warns that women who are pregnant or may become pregnant should not handle crushed or broken tablets because the active ingredient can be absorbed. Intact coating prevents contact during normal handling, but that protection does not apply after breakage. Separate the handling precaution from the independent contraindication to taking finasteride during pregnancy.
Apply it
A pregnant partner routinely splits a patient's finasteride tablets. Stop that handling arrangement and explain the distinction between intact coated tablets and exposed broken material; contact exposure should be washed promptly with soap and water.
Common pitfall: Calling the tablet coated does not make splitting safe for someone who may be pregnant. Breakage defeats the barrier relevant to normal handling.
47.How does finasteride change interpretation of PSA results?
Finasteride can lower serum prostate-specific antigen, so the medication history matters when interpreting PSA. The prescribing information advises evaluation of a confirmed increase from the lowest value during treatment even when the result remains within the reference range for untreated men. Assess trend, treatment exposure and adherence rather than relying solely on a laboratory normal flag. This is a medication-related interpretation issue, not a reason to diagnose prostate disease from one isolated measurement.
Apply it
A patient's PSA has risen on repeated testing from its lowest value during finasteride therapy but remains within the laboratory reference interval. Communicate the medication history and arrange evaluation rather than dismissing the trend as normal.
Common pitfall: A reference interval for untreated men does not erase a confirmed rise during therapy. Do not apply a universal numerical correction without the relevant context.
48.When should topical minoxidil benefit be assessed?
Topical minoxidil can support growth and maintenance in appropriate hair-loss presentations, but visible benefit takes time and varies between patients. The AAD describes assessment over months, commonly six to twelve months for noticeable results, rather than days. Confirm correct scalp application and ongoing use before interpreting an early lack of visible change. It cannot restore an entire head of hair, and its growth-supporting role does not establish treatment of an unidentified inflammatory cause of loss.
Apply it
A patient stops topical minoxidil after three weeks because photographs look unchanged. Review application and expectations, explain the longer assessment interval, and confirm that the underlying diagnosis remains appropriate for this treatment approach.
Common pitfall: An early photograph cannot establish treatment failure. Conversely, extending a trial indefinitely should not replace reassessment when the pattern or symptoms suggest another disease.
49.Why does successful medical treatment usually require maintenance?
Medical improvement in androgenetic alopecia generally depends on continued treatment because the underlying susceptibility persists. The AAD notes loss of minoxidil benefits after stopping, and finasteride prescribing information likewise describes reversal of effect after withdrawal. Distinguish a treatment-maintained result from a permanent cure. This matters when judging preoperative coverage and long-term transplant needs: a plan that relies on medically supported native hair should acknowledge what could happen if treatment is discontinued.
Apply it
A patient wants to stop all medication once density improves and then plan a small transplant around the improved appearance. Explain that native coverage may decline after withdrawal and incorporate that possibility into donor budgeting.
Common pitfall: Regrowth does not show that androgenetic susceptibility has disappeared. A stable appearance during treatment cannot be assumed to persist after treatment ends.
Hair Loss: Diagnosis and Treatment · DailyMed: Finasteride Tablets — Prescribing Information
50.What is platelet-rich plasma treatment intended to do?
PRP treatment processes a sample of the patient's blood and injects the selected plasma preparation into areas of hair loss. It is an autologous treatment approach, not transplantation of new follicles and not synonymous with stem-cell therapy. The AAD describes repeated treatments rather than a guaranteed permanent response to one injection. Discuss it within a diagnosis-based plan and assess outcomes over time without assuming that different preparation protocols produce identical effects or replace established treatment needs.
Apply it
A patient believes one PRP session will permanently replace all missing follicles. Explain the blood-processing and injection procedure, its need for follow-up treatment and the difference between supporting existing hair and surgically relocating follicles.
Common pitfall: Autologous does not mean guaranteed effective or permanent. PRP should not be described as follicle transplantation, cloning or proof of a stem-cell mechanism.
51.Why is growth stimulation alone insufficient for active FFA?
FFA management aims to stop progression and relieve inflammatory symptoms because lost follicles may be permanently damaged. Treatment commonly combines approaches; corticosteroids may address inflammation, while other therapies are selected for the individual clinical situation. Minoxidil may assist coexisting thinning but does not by itself control FFA. Judge success using disease activity and stability as well as hair thickness. Increased bulk in surviving hair cannot establish that the destructive hairline process has stopped.
Apply it
A patient with confirmed FFA uses minoxidil and reports thicker central hair, yet the frontal border remains symptomatic and receding. Reassess disease-directed treatment instead of interpreting central thickening as evidence of inflammatory stabilization.
Common pitfall: Cosmetic improvement can mask continued disease activity. Growth support and suppression of a scarring process are different treatment objectives and require separate assessment.
52.How should temporary shedding be managed differently from patterned loss?
A compatible telogen-effluvium presentation calls for identifying and addressing the trigger, explaining the delayed cycle response and monitoring recovery. Ongoing stressors can prolong shedding, and coexistence with patterned loss may require a separate treatment plan. Avoid assuming that every episode needs permanent surgical correction or that every patient needs the same growth medication. If a prescribed drug may be involved, discuss changes with its prescriber rather than recommending abrupt cessation of medically necessary treatment.
Apply it
A recovering patient with delayed diffuse shedding asks for immediate transplantation. Explain likely cycle-related recovery, assess whether the trigger persists and arrange follow-up to distinguish resolving shedding from any remaining underlying patterned thinning.
Common pitfall: Reassurance without examining the pattern can miss coexisting disease. Immediate surgery also risks committing donor hair before the reversible component has become clear.
Do You Have Hair Loss or Hair Shedding? · Hair Loss: Diagnosis and Treatment
Perioperative pharmacology and emergencies5–10%
53.How should cumulative lidocaine exposure guide another injection?
Convert concentration to milligrams and total every injection across donor and recipient regions: 1% lidocaine is 10 mg/mL, and 0.5% is 5 mg/mL. For normal healthy adults, the Xylocaine label gives a maximum individual lidocaine dose without epinephrine of 4.5 mg/kg, generally no more than 300 mg; with epinephrine, 7 mg/kg, generally no more than 500 mg. Apply the lower of the weight-based limit and total ceiling, then subtract prior exposure. These labeled limits for conventional use are distinct from specialized tumescent protocols and do not justify importing a higher tumescent dose into ordinary infiltration. Use the lowest effective dose. Reduce dosing for elderly, debilitated or acutely ill patients, and account for hepatic disease, impaired cardiovascular function and other relevant factors. An arithmetic balance is a ceiling check, not permission to administer that amount.
Apply it
In a conventional-infiltration exercise, a healthy 60-kg adult receives only plain lidocaine and no other local anesthetic. The limit is min(60 × 4.5, 300) = 270 mg. After 200 mg, the numerical balance is 70 mg, equivalent to 7 mL of 1%; a proposed further 10 mL would bring exposure to 300 mg and exceed the weight limit. In a separate healthy 80-kg adult receiving only lidocaine with epinephrine, min(80 × 7, 500) = 500 mg. After 350 mg, the balance is 150 mg, or 15 mL of 1%. Patient factors or clinical findings may require less. For concentration practice, 12 mL of 0.5% contains 60 mg.
Common pitfall: Dilution changes milligrams per millilitre, not cumulative drug already administered. Do not reset the total between donor and recipient injections. Toxicity can occur below a numerical limit, including after intravascular injection; mixed formulations or additional local anesthetics require assessment of the complete exposure.
FUE Clinical Practice Guidelines — July 15, 2019 · DailyMed - XYLOCAINE MPF- lidocaine hydrochloride injection, solution XYLOCAINE- lidocaine hydrochloride injection, solution XYLOCAINE- lidocaine hydrochloride,epinephrine bitartrate injection, solution
54.When should local-anesthetic systemic toxicity be suspected?
A seizure, arrhythmia or hypotension in the context of local-anesthetic administration should raise concern for LAST. Stop further administration, call for help, support airway and circulation, and obtain the LAST rescue kit while applying the specific checklist. Do not wait for every possible manifestation or assume the event is anxiety because the procedure uses local rather than general anesthesia. The temporal context and neurological or cardiovascular instability provide the discriminating emergency cues.
Apply it
During scalp anesthesia, a patient develops a seizure followed by hypotension. Stop the injection, activate emergency assistance and use the LAST pathway with airway support and early consideration of lipid emulsion rather than continuing treatment.
Common pitfall: The absence of a complete textbook symptom sequence does not exclude LAST. Local anesthesia does not remove the need for immediate resuscitation capability.
ASRA Local Anesthetic Systemic Toxicity Checklist — 2020, v1.1
55.How is lipid emulsion used in LAST rescue?
The ASRA 2020 v1.1 checklist calls for early consideration of 20% lipid emulsion alongside resuscitative care. For patients under 70 kg, give approximately 1.5 mL/kg over 2–3 minutes and infuse approximately 0.25 mL/kg/min. If instability persists, repeat the bolus and double the infusion. Continue lipid for more than 15 minutes after hemodynamic stability, observing the maximum total dose of 12 mL/kg. Lipid supplements airway, seizure and circulatory management rather than replacing them.
Apply it
For a 60-kg adult, give 90 mL of 20% lipid over 2–3 minutes and begin 15 mL/min. Persistent instability calls for another bolus and doubling to 30 mL/min. Continue for more than 15 minutes after stability; the cumulative maximum is 720 mL. Keep the ASRA checklist available during rehearsal.
Common pitfall: The initial 90-mL bolus is only the first treatment decision. Track response, infusion rate and cumulative volume; the maximum is a ceiling, not a target.
ASRA Local Anesthetic Systemic Toxicity Checklist — 2020, v1.1
56.Why does LAST resuscitation differ from standard ACLS?
ASRA's LAST checklist prefers benzodiazepines for seizures and an initial epinephrine dose of less than 1 microgram/kg. Avoid local anesthetics, beta-blockers, calcium-channel blockers and vasopressin during LAST resuscitation. Once stable, observe for 2 hours after seizure and 4–6 hours after cardiovascular instability; use an appropriate observation duration after cardiac arrest rather than assuming either shorter interval applies. These are LAST-specific recommendations and should be rehearsed with the 2020 v1.1 checklist.
Apply it
For a 60-kg patient, the initial epinephrine threshold is less than 60 micrograms. If a seizure is followed by hypotension, the cardiovascular event calls for 4–6 hours of observation after stabilization rather than the 2-hour seizure-only interval.
Common pitfall: Initial recovery does not complete the emergency response. Automatically applying ordinary ACLS drug choices or choosing observation solely from the neurological event can miss LAST-specific requirements.
ASRA Local Anesthetic Systemic Toxicity Checklist — 2020, v1.1 · ASRA Checklist for Treatment of Local Anesthetic Systemic Toxicity
Professional ethics1–5%
57.How should credentials and treatment claims be represented?
Represent the credential actually earned and describe procedures without misleading claims. The ABHRS ethics policy addresses accurate credential representation, truthful advertising and compensation that could influence care. Its advertising policy specifies “ABHRS Diplomate” rather than “Board Certified by the ABHRS.” This wording is an issuer policy. Clinical recommendations must remain tied to patient benefit rather than referral payments or sales pressure. Claims such as scarless FUE can mislead even when the procedure avoids a linear scar, because dispersed excision scars remain a material feature.
Apply it
An advertisement uses “Board Certified by the ABHRS” for a physician who has earned Diplomate status. Revise it to the issuer's specified “ABHRS Diplomate” designation. If only the separate written-only qualification was earned, do not claim Diplomate status.
Common pitfall: A technically true fragment can still mislead through implication. Avoiding a linear scar does not support advertising that patients will have no surgical scars.
ABHRS/IBHRS Code of Ethics Policy Statement · Guide to FUE Hair Transplant: Benefits, Process & Recovery
58.When can clinical photographs create a confidentiality problem?
Clinical documentation and public promotion serve different purposes, and permission for care should not be treated as automatic authorization for advertising use. Protect patient confidentiality when handling photographs and other identifying information. A cropped face does not necessarily remove every identifying feature or contextual link. Assess the intended disclosure and obtain appropriate authorization before using identifiable material publicly. The ethical question concerns the patient's information and agreed use, not merely whether the image demonstrates an impressive result.
Apply it
A clinic wants to post a recognizable scalp photograph taken for follow-up. Confirm authorization for that public use and remove unnecessary identifiers rather than assuming that attendance at the clinic permits promotional disclosure.
Common pitfall: A successful outcome does not waive confidentiality. Removing a name or partially cropping a photograph may leave the patient recognizable through other features.
History of hair restoration1–5%
59.How did scalp reduction differ from transplantation?
Historical scalp reduction removed bald scalp and advanced surrounding hair-bearing scalp to reduce the alopecic area. Transplantation instead transfers follicle-containing tissue from a donor region into recipient sites. A rotation flap moves a larger segment of hair-bearing scalp by a different reconstructive method. These distinctions help interpret old operative records and altered scalp anatomy. Recognize the operative principle rather than assuming that every historical hair-restoration procedure involved individual grafts comparable with contemporary follicular-unit surgery.
Apply it
An older operative note describes excision of bald vertex tissue followed by closure using adjacent hair-bearing scalp. Identify scalp reduction and consider the resulting scars and altered tissue relationships when assessing later restoration options.
Common pitfall: Scalp reduction is not donor-strip harvesting: the removed tissue is bald recipient scalp, rather than hair-bearing donor tissue intended for graft preparation.
60.Why did large round grafts prompt hairline-refinement techniques?
Older large round grafts could contain many hairs and create conspicuous clusters at a visible hairline. Modern refinement seeks a softer transition through more delicate graft selection and placement. Historical terms such as micrograft and minigraft often described hair-number categories rather than strict anatomical follicular units. Interpret old records using the definition used at the time. The lesson is that graft size, configuration and distribution affect naturalness independently of whether the transplanted hair successfully grows.
Apply it
A patient has well-growing but visibly clustered older frontal grafts. Describe the problem as an architectural and transition issue, then assess refinement options without equating good survival with an aesthetically natural hairline.
Common pitfall: An old minigraft label does not prove a single anatomical follicular unit. Likewise, replacing one historical term with modern wording does not change the graft's structure.
ISHRS Hair Restoration Glossary · Follicular Unit Transplantation & Extraction
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give the largest study share to surgical principles: diagnosis-based selection, sustainable hairline design, finite donor allocation and coherent long-term results.
- Distinguish gradual miniaturization, delayed telogen shedding, rapid anagen injury and symptomatic inflammatory loss; recognise that disorders can coexist.
- Calculate area-based demand, zone allocations, graft-versus-hair inventories and clearly denominated harvest-quality rates.
- Connect scalp layers, follicular histology and embryonic development to donor selection, graft integrity and the distinction between regrowth and new follicle formation.
- Separate growth support from disease stabilization, and explain maintenance, finasteride dosing, sexual adverse effects, pregnancy precautions and PSA interpretation accurately.
- Rehearse LAST with the ASRA 2020 v1.1 checklist, including lipid bolus, infusion, escalation, cumulative limit, epinephrine dosing and observation.
- Use the full official outline to extend beyond this selective guide, especially detailed anatomy, histology, embryology, pathology and historical references.
A practical preparation plan
1. Map study time to the written outline
Use the issuer's ten topics and approximate ranges to plan study. Start with surgical principles, then integrate diagnosis, donor harvesting, medical management and biology. Track uncovered outline topics separately so completing these 60 concepts does not become a substitute for full-scope preparation.
2. Explain diagnostic decisions aloud
For each alopecia case, state chronology, distribution, shaft changes, symptoms and donor findings. Explain what supports the leading diagnosis, what suggests another process and how confirmation would change treatment or surgical candidacy.
3. Work calculations with explicit units
Practise recipient area times additional graft density, separate zone totals, categorized graft inventories and graft-level versus follicle-level injury rates. Label every denominator and distinguish exercise assumptions from clinical recommendations.
4. Build a complete restoration plan
For an original case, connect diagnosis and progression to hairline position, donor reserve, regional priorities, technique, graft selection and follow-up. Explain how the plan changes if native hair declines or medical treatment stops.
5. Trace graft quality through the procedure
Follow a graft from donor assessment through excision, microscopic inspection, storage and placement. At each stage identify one mechanism of injury and a concrete response, including feedback that should change technique during the procedure.
6. Review drills and rehearse emergencies
Complete the 20 MCQs, justify the chosen option and explain why each alternative is less appropriate. Use flashcards for spaced recall, then rehearse LAST recognition and the complete lipid-rescue sequence with the checklist available. Keep written-drill performance separate from readiness for oral clinical problem solving.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Certification and Requirements for ABHRS and IBHRS Certification
- ABHRS Candidate Application Brochure
- Preparing for the Examination
- ABHRS Written Exam Percentages
- ABHRS/IBHRS Code of Ethics Policy Statement
- Hair Loss and the Hair Growth Cycle
- Follicular Unit Transplantation & Extraction
- Androgenetic Alopecia: A Guide to Pattern Hair Loss
- Do You Have Hair Loss or Hair Shedding?
- Frontal Fibrosing Alopecia: Diagnosis and Treatment
- About Your New Hairline
- Harvesting of Donor Hair for Hair Transplants
- Guide to FUE Hair Transplant: Benefits, Process & Recovery
- ISHRS Hair Restoration Glossary
- FUE Clinical Practice Guidelines — July 15, 2019
- Guide to Currently Accepted FUE and Implanter Terminology — July 15, 2019
- Hair Graft Placement: The Final Step in Hair Transplantation
- Hair Loss: Diagnosis and Treatment
- DailyMed: Finasteride Tablets — Prescribing Information
- ASRA Checklist for Treatment of Local Anesthetic Systemic Toxicity
- ASRA Local Anesthetic Systemic Toxicity Checklist — 2020, v1.1
- Why Your Hair Restoration Specialist Should Be a Physician - ISHRS
- Improve FUE: Mechanically and Electronically-Assisted Help Improve transection rates of FUE. Improvements in instrument technology and technique have made FUE a procedure competitive with strip harvesting for obtaining donor hair for hair transplantation: Benefits For Both Patient and Surgeon.
- HAIR FOLLICLE ORIGIN - ISHRS
- Uncover Hair Loss Causes & Solutions for Men & Women – Here's How!
- COMPARISON BETWEEN STRIP HARVESTING AND FOLLICULAR UNIT EXTRACTION: A FAIR AND BALANCED VIEW - ISHRS
- DailyMed - XYLOCAINE MPF- lidocaine hydrochloride injection, solution XYLOCAINE- lidocaine hydrochloride injection, solution XYLOCAINE- lidocaine hydrochloride,epinephrine bitartrate injection, solution
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.